IceCure Medical (ICCM) Net Shares Issued and Repurchased (2020 - 2025)

IceCure Medical (ICCM) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $61307.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 169.94% year-over-year to $61307.0 in Q4 2025; TTM through Dec 2025 was $61307.0, a 169.94% increase from a year earlier, with the FY2025 full-year figure at $61307.0, up 169.94% from the prior year.
• Net Shares Issued and Repurchased was $61307.0 for Q4 2025 at IceCure Medical, up from $22711.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $1.8 million in Q4 2022 and troughed at $22711.0 in Q4 2024.
• A 5-year average of $631440.6 and a median of $108929.0 in 2021 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased surged 1558.25% in 2022 and sank 98.04% in 2024, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $108929.0 in 2021, then surged by 1558.25% to $1.8 million in 2022, then tumbled by 35.89% to $1.2 million in 2023, then slumped by 98.04% to $22711.0 in 2024, then soared by 169.94% to $61307.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $61307.0 (Q4 2025), $22711.0 (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.